What Does Leuko Do?

Total employees15
HeadquartersCambridge
Founded2017

Leuko Labs is a medical technology company at the forefront of hematology innovation. They are dedicated to developing PointCheck™, the world's first non-invasive device for monitoring white blood cell levels. This breakthrough technology aims to significantly improve the quality of life and treatment outcomes for immunosuppressed patients, such as those undergoing chemotherapy, by enabling convenient and frequent monitoring without the need for blood draws. Their mission is to empower patients and clinicians with actionable health insights, reducing risks of infection and hospitalizations.

Where Is Leuko's Headquarters?

HQ Function

The headquarters serves as the primary center for research and development, engineering, clinical trial management, and corporate operations for Leuko Labs.

Notable Features:

Located in Kendall Square, offering proximity to MIT, renowned research institutions, and a vibrant ecosystem of startups and established life science companies. The facilities likely include advanced laboratories for device development and testing.

Work Culture:

Leuko Labs fosters an innovative, collaborative, and mission-driven work environment. The culture emphasizes scientific rigor, patient-centric solutions, and a fast-paced startup dynamism, attracting talent passionate about making a tangible impact in healthcare.

HQ Significance:

Its Cambridge location is highly significant, providing access to top-tier talent, cutting-edge research, potential strategic partnerships, and venture capital, all crucial for a medical technology company's growth and success.

Values Reflected in HQ: The headquarters' strategic location and focus on R&D reflect Leuko Labs' core values of innovation, scientific excellence, and a commitment to solving critical unmet medical needs.

Location:

While Leuko Labs is headquartered and currently focuses its primary operations in the United States, its innovative PointCheck™ technology for non-invasive white blood cell monitoring addresses a universal healthcare need. The company's vision is global, aiming to eventually bring its solution to immunosuppressed patients worldwide. Future global presence will likely involve strategic partnerships for distribution, regulatory approvals in different regions (e.g., Europe, Asia), and participation in international clinical studies.

Street Address:

245 Main Street

City:

Cambridge

State/Province:

MA

Country:

USA

Where Else Does Leuko Operate Around the World?

Cambridge, MA/USA (Primary Operations)

Address: Operations are centralized at 245 Main Street, Cambridge, MA

The primary focus is on leveraging the Boston/Cambridge biotech ecosystem for innovation and initial market development in North America.

Buying Intent Signals for Leuko

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Leuko? Meet the Executive Team

As of April 2025, Leuko' leadership includes:

Carlos Castro-Gonzalez, PhD - Co-founder & CEO
Ian Butterworth, PhD - Co-founder & CTO
Aurelien SchMAdel, PhD - Co-founder & CSO
Alvaro Peralta, PhD - Head of Clinical & Regulatory

Who's Investing in Leuko?

Leuko has been backed by several prominent investors over the years, including:

Good Growth Capital
Pegasus Tech Ventures
Nina Capital
SOSV
HAX
Takeda Digital Ventures
NSF (National Science Foundation)
NIH (National Institutes of Health)
XTX Ventures
Mustard Seed MAZE

What Leadership Changes Has Leuko Seen Recently?

Hire0
Exits0

Public information and news searches over the last 12 months do not indicate significant C-suite level new hires or departures at Leuko Labs. The company's founding leadership team appears to remain consistent as they advance their PointCheck™ technology.

Departures

Not Publicly Reported, No specific senior executive departures have been publicly announced by Leuko Labs in the last 12 months.

New Appointments:

Not Publicly Reported, No specific new senior executive appointments have been publicly announced by Leuko Labs in the last 12 months.

What Technology (Tech Stack) Is Used byLeuko?

Discover the tools Leuko uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Leuko Email Formats and Examples

Common email formats for technology and life science companies like Leuko Labs often utilize patterns such as first initial followed by last name, or first name separated from last name by a dot, all preceding '@leukolabs.com'. The exact internal convention isn't publicly specified.

[first_initial][last]@leukolabs.com (e.g., jdoe@leukolabs.com) or [first].[last]@leukolabs.com (e.g., jane.doe@leukolabs.com)

Format

ccastrogonzalez@leukolabs.com (speculative example for Carlos Castro-Gonzalez based on a common format)

Example

70%

Success rate

What's the Latest News About Leuko?

Leuko Labs News / NASANovember 16, 2023

Leuko Labs Wins First Place at the 2023 NASA iTech Cycle II Forum

Leuko Labs was awarded first place at the 2023 NASA iTech Cycle II Forum for its innovative PointCheck™ technology, highlighting its potential impact and application in various environments, including space exploration....more

Leuko Labs News / PR NewswireSeptember 19, 2023

Leuko Labs Awarded Direct-to-Phase II SBIR Grant from NCI to Validate PointCheck™ Device

Leuko Labs received a significant Direct-to-Phase II Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI). This funding supports the further validation of its PointCheck™ device in chemotherapy patients, a critical step towards clinical adoption....more

MedTech InnovatorMay 23, 2023

Leuko Labs Selected as Finalist in 2023 MedTech Innovator Global Competition

Leuko Labs was chosen as one of the 61 companies for the 2023 Cohort of MedTech Innovator, the world’s largest accelerator of medical technology companies. This selection recognized Leuko Labs' potential to transform healthcare with its non-invasive white blood cell monitoring technology....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Leuko, are just a search away.